Correction to: siRNA modification and delivery for drug development: (Trends in Molecular Medicine, 28:10 p:892–893, 2022) (Trends in Molecular Medicine (2022) 28(10) (892–893), (S1471491422002040), (10.1016/j.molmed.2022.08.003))

In the original version of Figure 2, we showed some examples of chemical modification designs. In order to provide more accurate information, we changed several 2′-O-methyl (2′-OMe) modification sites with 2′-deoxy-2′-fluoro (2′-F) in the second example in Figure 2. We also slightly modified the chemical structures of inverted abasic deoxyribonucleotide (invAb). We apologize for any confusion this caused.[Formula